BrightOwl Loader Loading


Dr Dinah Parums has medical degrees from the University of Cambridge (BA, MA) and Oxford University Medical School (BM, BCh). Her PhD is in experimental pathology (cellular pathology and immunopathology) from the University of Cambridge.

During her postgraduate medical career, Dinah was awarded research fellowships from the British Heart Foundation, Wolfson College, Oxford and Darwin College, Cambridge and held visiting fellowships at the Massachusetts General Hospital (MGH) and Stanford University Medical School, USA.

Dinah’s postgraduate specialist training was in surgical and anatomic pathology at the John Radcliffe Hospital, Oxford where she was a Clinical Lecturer and Clinical Tutor, University of Oxford. She was awarded Membership of the Royal College of Pathologists (MRCPath) in 1991 and elected to the Fellowship (FRCPath) in 1999. In 1999, she was awarded the Fellowship of the American College of Chest Physicians (FCCP).

Dinah has held senior clinical and academic positions at the Royal Postgraduate Medical School, Hammersmith Hospital, University of London and University of Cambridge. From 1995 to 2002, she was External Examiner for the Royal College of Pathologists. She has more than ten years of experience working as a consultant to the pharmaceutical industry and as a principal pharmaceutical physician.

Dinah has more than 40 peer-reviewed publications and more than 20 years of experience in postgraduate medical teaching and in reviewing manuscripts for biomedical journals. She has worked as a Clinical Editor for the British Medical Journal (BMJ).

In support of her current role, Dr Dinah Parums is a member of the National Union of Journalists (NUJ), the American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA) and the International Society for Medical Publication Professionals (ISMPP). She is familiar with the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), and the Good Publication Practice (GPP3) guidelines.


Current Experience

  • Medical & Science Writer / Editor / Consultant Oxford, United Kingdom
    Since January 2014

    1. Freelance experience at the Senior Medical Writer level in manuscript writing, editing, publication planning and medical education. Subject areas: medicine, surgery, pathology, oncology, medical devices, life sciences, targeted therapy, immune therapy, tissue repair, molecular biology, drug development.
    2. Manuscript editing for English as a second language (ESL).
    3. Consulting work in medicine and life sciences, including: * Providing literature reviews & writing review updates in life sciences. * Communicating with key opinion leaders (KOLs) in medicine & translational science. * Providing specialist input to medical & scientific projects involving diagnostics, translational science & biomarker studies (oncology, pulmonary, cardiovascular, inflammation, immunology & tissue repair). * Copywriting for web pages, science & health blogs, white papers, B2B documents, executive documents, press releases, teaching documents & marketing communications.
    4. Freelance writing support for medical eduction: * Medical student and postgraduate training material (all disease areas and specialties) * Teaching material for higher degrees (BSc, MSc & PhD) * Writing for physicians and surgeons (CME & CPD) * Patient information
    5. Freelance medical and science journalism.
    6. In support of these current roles: * Membership of the National Union of Journalists (NUJ), the American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA) and the International Society for Medical Publication Professionals (ISMPP). * Knowledge of the current guidelines from the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), the AMA Manual of Style (10th Edition) and the current Good Publication Practice (GPP3) guidelines.

Past Experience

  • Contributing Author, Life Science Connect
    February 2014 --- August 2015
    From February 2014, at the invitation of Karla Burke, Life Sciences Senior Marketing Specialist at Thomson Reuters Life Science Connect, a series of 20 online articles have been published. These news and review articles may be found at: Topics include: Immune recognition; targeted therapy for NSCLC (including immune therapy); the role of the pathologist in targeting therapy; dietary hypotheses of atherosclerosis; L-carnitine and IHD; ‘crowdfunding’ and its supporting role in life sciences; the NIH NCATS and TRND programmes. At the invitation of publishers Prous Science, two single-author review articles have been written and published in 2014 on the current status of targeted therapy and immune therapy (including vaccines) in cancer, for Drugs of Today and Drugs of the Future.

  • Principal Pharmaceutical Physician (Pathologist), Discovery Medicine, Medical Science, Oncology
    January 2004 --- January 2008
    This role involved developing a new capability (Histopathology) within Astrazeneca which supported the pre-clinical and clinical translational science Oncology biomarker programme. The role involved in-house and outsourced tissue biomarker and pharmocogenetics analysis. Evaluation of the light microscopic appearance of human and animal tissue samples and immunohistochemistry (IHC) signals to support projects was involved. This role included the evaluation of external providers of histopathology, IHC and pharmacogenomics worldwide, resulting in a Preferred Providers list with interactions with clinical and scientific key opinion leaders (KOLs). This resulted in the development of a Quality Plan for outsourced project work. Other experience gained in industry has included writing patents, SOPs, training manuals and guidelines including e-learning modules for use in clinical trials. Specialist expertise brought the added value of being Pathology adviser on the Hepatotoxicity Advisory Panel and the Safety Knowledge Group with review of cases and reports for Global Drug Safety and drug safety physicians. Such high level specialist input was provided in 2004/2005 in to the ISEL study (for IRESSA) with biomarker data delivery to the FDA; this was the largest biomarker study to date undertaken in a clinical trial. This study provided the model for support for the then ongoing Phase III, tissue-based biomarker studies (Iressa, Zactima, Recentin).

  • Clinical Editor
    August 2003 --- February 2004
    Six month, full-time position with the British Medical Journal. 'Knowledge Group'. As Clinical Editor, this role involved: • Planning content– assessing current coverage and developments in that area of medicine, then liaising with colleagues and expert authors to develop structure and agree coverage. • Selecting peer reviewers and arranging peer review as needed. • Critically appraising systematic reviews, RCTs, or other evidence. • Rewriting content to ensure it is clear, understandable, and clinically useful. • Editing content, incorporating feedback from colleagues and peer reviewers, and liaising with expert authors to ensure content is delivered to production within agreed time-frame. • Participating in projects to enhance content and editorial processes. • Supporting less experienced colleagues as needed and providing advice. • Attending meetings as necessary, both internal and external. • Acting as an ambassador / promoting BMJ Knowledge products nationally and internationally. Before commencing this role, a BMJ Point of Care/Best Practice Editing Test was required, involving: 1. Adherence to instructions 2. Assessment of content 3. Communicative style 4. Attention to detail.

  • Senior Lecturer and Consultant
    September 1993 --- September 2003
    Consultant and Senior Lecturer in Histopathology for the NHS and University involved clinical diagnosis, clinical management, teaching and research. Specialty diagnostic interests included immunohistochemistry, oncological pathology, pulmonary and cardiovascular pathology. Post mortems were done for clinical purposes and on behalf of Her Majesty's Coroner. Training of junior doctors was a key role and from 1995 to 2002, so was the role of an External Examiner for Membership of the Royal College of Pathologists. Specialist referral work for review of cases and medico-legal expert witness work was done between 1994 and 2003.

  • Postgraduate Teaching Experience
    September 1984 --- August 2003
    Dr Dinah Parums has teaching experience at all levels. From 1990 to 1993, Pathology representative on the Curriculum and Examinations Committee, Oxford University Medical School. From 1989 to 1993, College Adviser, Wolfson College, Oxford and Clinical Adviser, Oxford University Medical School. From January 1993 to April 1994, Pathology representative on the Committee for the Review of the Clinical School, Board of the Faculty of Clinical Medicine, Oxford University (Chairman: Professor Sir David Weatherall). As Senior Lecturer and Consultant in Histopathology, Royal Postgraduate Medical School, Hammersmith Hospital, London from 1993 to 1996, organising and teaching in the Advanced Surgical Pathology Course, teaching the whole of the Pulmonary Pathology session; a one week postgraduate course, Update in Cardiovascular Pathology, in September 1994; the Cardiovascular modules of the MSc Course in Histopathology in 1996 and the MSc Course in Experimental Pathology and Toxicology in 1994 and 1995 and the Diploma in Clinical Pathology (Histopathology) from 1993 to 1995.

  • External consultant
    January 1997 --- January 2002
    As an external Consultant for Pfizer Global R&D, the role was to supervise tissue-based R&D projects across multiple therapeutic areas. These included cardiovascular, genitourinary, CNS, respiratory, inflammation and tissue repair. Biomarker analysis involved interpretation of immunohistochemistry and non isotopic in-situ hybridisation studies. The role also involved review of project proposals and data, literature review and presentation of disease processes and mechanisms aligned with projects. Writing and reviewing reports, attending and presenting data at national and international scientific symposia and meetings on behalf of the company, liaising with KOLs in these disease and therapeutic areas were part of this role. A number of patents and publications resulted from these collaborations.


Self Assessment :
Attention to detailCritical thinkingDiligence


LinkedIn Assessment :
Clinical trialsPharmaceutical IndustryLife SciencesClinical researchBiotechnologyMedicineLifesciencesoncologyCancerHealthcarePatient SafetyResearchsciencemolecular biologyMedical writingClinical DevelopmentImmunohistochemistryPathologyTranslational MedicineToxicologyBiomarkersScientific WritingImmunologyMedical EducationGeneticsMedical ResearchUniversity TeachingSurgical PathologyEditorialLaboratory MedicineHistopathologyHistologyPublishingMedical DiagnosticsHematologyClinical PathologyVirologyCell biologyMicrobiologyCopywritingCopy EditingEditingJournalismCreative WritingProofreadingPeer ReviewsWritingBiomedical SciencesMicrosoft WordPublications

Skills and Expertise

Self Assessment :
CopywritingCopy editingPublication of articlesManuscript preparationManuscript reviewpublication planningMedical Journalismwriting and editing Write papersManuscript preparation and review


  • PhD in Pathology from University of Cambridge in 1987
  • Doctor of Philosophy (PhD) in Pathology/Experimental Pathology from Harvard Medical School in 1986
  • B.M., B.Ch. in Clinical Medicine from University of Oxford in 1983
  • B.A.(Hons) Medical Sciences in Medicine (and Pathology), King's College from University of Cambridge in 1980

Training and Certification

  • B.A. (Hons) certificate, Medical Sciences, Certification
  • B.M.,B.Ch. degree Certification
  • Certificate of Merit Certification
  • Completion of Annual CME/CPD certification (1995 to 2005) Certification
  • D.Phil (by incorporation) Certification
  • Fellowship of the American College of Chest Physicians (FCCP) Certification
  • Fellowship of the Royal College of Pathologists (FRCPath) Certification
  • M.A. (by incorporation) Certification
  • M.A. degree Certification
  • Membership of the Royal College of Pathologists (MRCPath) Certification
  • PhD (Pathology) Certification
  • World Who's Who of Women Certification


BrightOwl Assessment:
Self Assessment:

Work Preferences

  • Notice Period:
    4 weeks
  • Positions I am interested in:
    Freelance Science Writer Medical Writer Scientific Writer Senior Medical Writer
  • Positions I am NOT interested in:
    I prefer to work from home.
  • Locations I am interested in:
  • Work From Home:
    Yes, 0 to 5 days per week
  • Work Regime:
    BrightOwl freelancer :    up to 40 Hours per week
  • International:


    Expert has 2 publications (Will be avalible with full profile)

Area / Region

Oxford, United Kingdom


Driving License
  • Yes